Institute for Interdisciplinary
Innovation in healthcare
Support the I3h Institute
I3h
Donations which are tax deductible above 40€ can be made by a bank transfer. Thank you!
I3h
Le système immunitaire face au virus SARS-CoV-2
Leçon de clôture du Professeur Michel Goldman
Titulaire du cours d’immunologie médicale
à l’Université libre de Bruxelles de 1995 à 2020
I3h
Le Monde – Tribunes
Our co-directors, Michel Goldman and Mathias Dewatripont have recently published two articles in Le Monde where they argue that public trust is the backbone of any immunization strategy and discuss the economic impact of lockdowns.
I3h seminars
08 March, 12:30
What pharma ownership means
for its optimal regulation
Antonio Estache
Professor of Economics, Université Libre de Bruxelles
Research Fellow, European Center for Advanced Research in Economics and Statistics (ECARES)
Conférence – débat avec Moncef Slaoui, Philippe Aghion et Beatrice Delvaux
I3h
mRNA vaccine safety
The world’s first mRNA vaccine has begun its rollout after being produced at unprecedented speed as part of the global effort to end the Covid-19 pandemic. In trials these vaccines have shown to be at least 94% effective at preventing people from falling ill with Covid-19. But how safe is this new technology?
In an interview given to Horizon: the EU Research & Innovation magazine our co-director, Michel Goldman sheds light on five key facts about the mRNA vaccines.
I3h